Co-Authors
This is a "connection" page, showing publications co-authored by Douglas Fraser and Marat Slessarev.
Connection Strength
2.217
-
Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets. Crit Care Explor. 2020 Oct; 2(10):e0246.
Score: 0.908
-
Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2021 Mar; 3(3):e0369.
Score: 0.233
-
Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Crit Care Explor. 2020 Oct; 2(10):e0272.
Score: 0.227
-
Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation. Crit Care Explor. 2020 Sep; 2(9):e0194.
Score: 0.225
-
Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020 Sep; 2(9):e0189.
Score: 0.225
-
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020 Jun; 2(6):e0144.
Score: 0.222
-
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern. JCI Insight. 2021 07 08; 6(13).
Score: 0.060
-
Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021 06; 19(6):1546-1557.
Score: 0.059
-
Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation. Intensive Care Med Exp. 2020 Dec 11; 8(1):75.
Score: 0.057